David Chang

Chief Executive Officer • WuXi Advanced Therapies

Dr. David Chang, Chief Executive Officer at WuXi Advanced Therapies and OXGENE, holds a wealth of experience in the cell and gene therapy industry, including biopharmaceutical technical development, manufacturing operations, engineering, and strategy. Prior to joining WuXi Advanced Therapies, David held the role of Corporate Vice President and Head of Cell Therapy Global Manufacturing at Celgene Corporation, a Bristol-Myers Squibb Company, where he oversaw the global CAR-T manufacturing network and technologies. David earned a bachelor’s in chemical engineering from National Taiwan University and holds a Ph.D. in biochemical engineering from the Massachusetts Institute of Technology.

Also Speaking

Wilson Bryan

Director, Office of Tissues and Advanced Therapies • FDA

Ana Rosa Sáez Ibáñez

Research Analyst, Clinical Accelerator and Venture Fund • Cancer Research Institute

Jenny Ligon

Associate Director, Workforce Development • National Center for Therapeutics Manufacturing (NCTM)

Also Speaking


Germfree Truck



Book your hotel room for your stay in Miami.